1. Companies

  2. Leap Therapeutics

Leap Therapeutics

Leap Therapeutics

Verified
A biopharmaceutical company in the clinical stage, acquiring and advancing innovative therapeutics at the forefront of cancer research.
Launch date
Employees
11-50 people
Market cap
$91.1m
Net debt
$54.3m
Enterprise valuation
$37m (Public information from May 2024)
Cambridge Massachusetts (HQ)
http://leaptx.com
https://twitter.com/leaptherapeutichttps://www.facebook.com/leaptxhttps://www.linkedin.com/company/leap-therapeutics
View job openings
Deals in current and previous year:

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2018201920202021202220232024
Revenues0000000000000000000000000000
EBITDA0000000000000000000000000000
% EBITDA margin--(1881 %)(2679 %)---
Profit0000000000000000000000000000
% profit margin--(1834 %)(2706 %)---
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue--1362 %2144 %---
    • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
N/A

$0.0

round
investor

$0.0

round
N/A

$0.0

round
*

$40.0m

Private Placement VC
Total Funding000k

Related Content

Recent News about Leap Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Leap Therapeutics

Edit
MacroCure
MacroCure
ACQUISITION by Leap Therapeutics Aug 2016
Flame Biosciences
Flame Biosciences
ACQUISITION by Leap Therapeutics Jan 2023